转移性黑色素瘤联合化疗与特异性主动免疫疗法的临床试验
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
作者信息
Newlands E S, Oon C J, Roberts J T, Elliott P, Mould R F, Topham C, Madden F J, Newton K A, Westbury G
出版信息
Br J Cancer. 1976 Aug;34(2):174-9. doi: 10.1038/bjc.1976.140.
Abstract
Fifty-six patients with disseminated malignant melanoma were randomly allocated to two treatment groups. The first group C received combination chemotherapy consisting of DTIC and ICRF 159. The second group (C+I) received the same chemotherapy but were also immunized with 2 X 10(7) irradiated allogeneic melanoma cells mixed with 50 mug of percutaneous BCG. The survival rates in both treatment groups C and (C+I) were not significantly different, and only minor enhancement of the chemotherapy was found in the (C+I) group. A similar pattern of tissue response was observed in both groups: lymph node, skin and, to some extent liver metastases, respond better than other sites.
摘要
56例播散性恶性黑色素瘤患者被随机分为两个治疗组。第一组C接受由达卡巴嗪（DTIC）和丙亚胺（ICRF 159）组成的联合化疗。第二组（C + I）接受相同的化疗，但同时用2×10⁷经照射的同种异体黑色素瘤细胞与50微克经皮卡介苗混合进行免疫。治疗组C和（C + I）的生存率无显著差异，且在（C + I）组仅发现化疗有轻微增强。两组观察到相似的组织反应模式：淋巴结、皮肤以及在一定程度上肝转移灶的反应优于其他部位。
相似文献
1
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.转移性黑色素瘤联合化疗与特异性主动免疫疗法的临床试验
Br J Cancer. 1976 Aug;34(2):174-9. doi: 10.1038/bjc.1976.140.
2
3
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.卡介苗免疫疗法联合达卡巴嗪（NSC-45388）治疗恶性黑色素瘤。
Cancer Treat Rep. 1976 Feb;60(2):177-82.
4
Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.接受化疗和特异性主动免疫治疗的播散性恶性黑色素瘤患者的肿瘤消退及生存情况
Eur J Cancer (1965). 1977 Oct;13(10):1169-73. doi: 10.1016/0014-2964(77)90017-2.
5
Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.化疗免疫疗法治疗播散性恶性黑色素瘤：一项前瞻性随机研究。
Cancer Treat Rep. 1978 Jul;62(7):1085-7.
6
Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.恶性黑色素瘤的辅助治疗：免疫疗法、化疗及联合治疗的试验
Recent Results Cancer Res. 1978;68:380-6. doi: 10.1007/978-3-642-81332-0_57.
7
Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.恶性黑色素瘤手术辅助治疗中延长化疗、免疫治疗及化疗联合免疫治疗的对照研究（试验6）：初步报告
Recent Results Cancer Res. 1978;68:375-9. doi: 10.1007/978-3-642-81332-0_56.
8
Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.“高危”原发性恶性黑色素瘤辅助治疗的随机试验
Surgery. 1978 Jun;83(6):677-81.
9
Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.主动免疫疗法作为化疗辅助手段治疗播散性恶性黑色素瘤的一项初步研究。
Br J Cancer. 1975 Feb;31(2):143-56. doi: 10.1038/bjc.1975.19.
10
The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.接受卡介苗（BCG）治疗（无论是否联合化疗）的恶性黑色素瘤患者的生存率。
Aust N Z J Surg. 1979 Jun;49(3):335-9. doi: 10.1111/j.1445-2197.1979.tb07675.x.
引用本文的文献
1
Efficacy and safety of cancer vaccine therapy in malignant melanoma: a systematic review.癌症疫苗疗法在恶性黑色素瘤中的疗效与安全性：一项系统评价
Int J Clin Oncol. 2025 May 6. doi: 10.1007/s10147-025-02753-x.
2
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.靶向核苷酸代谢：增强癌症免疫治疗的有前途的方法。
J Hematol Oncol. 2022 Apr 27;15(1):45. doi: 10.1186/s13045-022-01263-x.
3
A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma.贝叶斯网络荟萃分析比较黑色素瘤的癌症治疗性疫苗。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1976-1986. doi: 10.1111/jdv.17437. Epub 2021 Jun 29.
4
Cryotherapy for liver metastases.肝转移瘤的冷冻治疗
Cochrane Database Syst Rev. 2019 Jul 10;7(7):CD009058. doi: 10.1002/14651858.CD009058.pub3.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Strategy in the management of melanoma.黑色素瘤的管理策略。
Proc R Soc Med. 1977 Jun;70(6):395-7. doi: 10.1177/003591577707000607.
7
Malignant melanoma and immunotherapy.恶性黑色素瘤与免疫疗法
Br Med J. 1976 Oct 9;2(6040):831-2.
8
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.特异性主动免疫疗法并不能延长IIB期恶性黑色素瘤手术治疗患者的生存期，且可能会促进早期复发。
Br J Cancer. 1978 Apr;37(4):491-6. doi: 10.1038/bjc.1978.76.
9
Combined modality therapy of malignant melanoma.恶性黑色素瘤的综合治疗
World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586.
10
Chemotherapy of malignant melanoma.恶性黑色素瘤的化疗
World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584.
本文引用的文献
1
Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.短小棒状杆菌主动免疫疗法与化疗对小鼠纤维肉瘤的作用
Br Med J. 1970 Feb 28;1(5695):541-4. doi: 10.1136/bmj.1.5695.541.
2
Combination phase 1-II study of imidazole carboxamide (NCS45388).咪唑甲酰胺（NCS45388）的1-2期联合研究
Oncology. 1972;26(2):310-6. doi: 10.1159/000224680.
3
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.恶性黑色素瘤中经照射的肿瘤细胞免疫接种及特异性淋巴细胞细胞毒性
Br Med J. 1971 May 8;2(5757):305-10. doi: 10.1136/bmj.2.5757.305.
4
Autoimmunization with irradiated tumour cells in human malignant melanoma.人类恶性黑色素瘤中经辐射的肿瘤细胞自身免疫作用
Br Med J. 1970 Jun 27;2(5712):752-4. doi: 10.1136/bmj.2.5712.752.
5
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.用二甲基三氮烯咪唑甲酰胺和卡介苗对播散性恶性黑色素瘤进行化学免疫治疗。
N Engl J Med. 1974 Sep 19;291(12):592-7. doi: 10.1056/NEJM197409192911202.
6
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.晚期转移性恶性黑色素瘤的预后相关性及对治疗的反应
Cancer Res. 1974 Aug;34(8):1995-2004.
7
Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.化疗在实体瘤综合治疗中的应用。IV. 恶性黑色素瘤。
Cancer Treat Rev. 1974 Dec;1(4):285-304. doi: 10.1016/s0305-7372(74)80020-4.
8
Chemotherapy of malignant melanoma.恶性黑色素瘤的化疗
Cancer. 1972 Dec;30(6):1604-15. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5.
9
T-lymphocyte responses in patients with malignant melanoma.恶性黑色素瘤患者的T淋巴细胞反应。
Eur J Cancer (1965). 1974 Oct;10(10):639-46. doi: 10.1016/0014-2964(74)90002-4.
10
Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.转移性恶性黑色素瘤的化疗。73例患者的经验。
Cancer. 1971 Jun;27(6):1306-12. doi: 10.1002/1097-0142(197106)27:6<1306::aid-cncr2820270605>3.0.co;2-r.
Zotero 插件